Insider transactions

EDGAR

Aethlon Medical, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-19.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–19 of 19

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-08 Filed 2026-10-15LAROSA STEVEN P Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)42,0000.00
0

Derived: shares × price per share. Exact value 0.00.

42,057Direct (D) No
F1
  • F1 Represents a grant of 42,000 restricted stock units (RSUs) pursuant to the Issuer's 2020 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest over the one-year period following October 8, 2026, subject to the Reporting Person's continued service through the applicable vesting dates. Notwithstanding the foregoing, the RSUs will become fully vested upon the closing of the Issuer's proposed merger with North Immunology, Inc.
Open filing 0001683168-26-007901 Read from the filing’s XML Dispute this row
2026-10-08 Filed 2026-10-13FRAKES JAMES B Director · Officer: CFO/CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)42,0000.00
0

Derived: shares × price per share. Exact value 0.00.

42,063Direct (D) No
F1
  • F1 Represents a grant of 42,000 restricted stock units (RSUs) pursuant to the Issuer's 2020 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest over the one-year period following October 8, 2026, subject to the Reporting Person's continued service through the applicable vesting dates. Notwithstanding the foregoing, the RSUs will become fully vested upon the closing of the Issuer's proposed merger with North Immunology, Inc.
Open filing 0001683168-26-007822 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-15BROENNIMAN EDWARD G Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)2186.52
1,421.36

Derived: shares × price per share. Exact value 1421.36.

4,313Direct (D) No
F1, F2
  • F1 The Reporting Person forfeited 218 shares of common stock upon conversion of an aggregate 1,091 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2026.
  • F2 The amount of securities beneficially owned is being amended to account for a typographical error in the Form 4 filed on April 21, 2026. The number of shares beneficially owned following the reported transaction was shown as 23,454 shares, but should have been 23,730.
Open filing 0001683168-26-007878 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-15Shah Chetan Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)4366.52
2,842.72

Derived: shares × price per share. Exact value 2842.72.

3,787Direct (D) No
F1, F2
  • F1 The Reporting Person forfeited 436 shares of common stock upon conversion of an aggregate 1,091 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2026.
  • F2 The amount of securities beneficially owned is being amended to account for a typographical error in the Form 4 filed on April 21, 2026. The number of shares beneficially owned following the reported transaction was shown as 23,021 shares, but should have been 23,278.
Open filing 0001683168-26-007881 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-15Gikakis Nicolas Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)4366.52
2,842.72

Derived: shares × price per share. Exact value 2842.72.

3,784Direct (D) No
F1, F2
  • F1 The Reporting Person forfeited 436 shares of common stock upon conversion of an aggregate 1,091 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2026.
  • F2 The amount of securities beneficially owned is being amended to account for a typographical error in the Form 4 filed on April 21, 2026. The number of shares beneficially owned following the reported transaction was shown as 22,844 shares, but should have been 23,279.
Open filing 0001683168-26-007879 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-01Gikakis Nicolas Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)2,1820.82
1,789.24

Derived: shares × price per share. Exact value 1789.24.

20,663Direct (D) No
F1
  • F1 The Reporting Person forfeited 2,182 shares of common stock upon conversion of an aggregate 5,454 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2026.
Open filing 0001683168-26-005225 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-01Shah Chetan Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)2,1820.82
1,789.24

Derived: shares × price per share. Exact value 1789.24.

20,840Direct (D) No
F1
  • F1 The Reporting Person forfeited 2,182 shares of common stock upon conversion of an aggregate 5,454 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2026.
Open filing 0001683168-26-005226 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-01BROENNIMAN EDWARD G Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)1,0910.82
894.62

Derived: shares × price per share. Exact value 894.62.

22,363Direct (D) No
F1
  • F1 The Reporting Person forfeited 1,091 shares of common stock upon conversion of an aggregate 5,454 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2026.
Open filing 0001683168-26-005224 Read from the filing’s XML Dispute this row
2026-04-17 Filed 2026-10-15Rossetti Angela Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)21,8152.29
49,956.35

Derived: shares × price per share. Exact value 49956.35.

4,846Direct (D) No
F1, F2
  • F1 The Reporting Person was granted RSUs that vest in four equal quarterly installments on each of June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027, subject to the Reporting Person's continued service with the Company on each such vesting date.
  • F2 The amount of securities beneficially owned is being amended to account for a typographical error in the Form 4 filed on April 21, 2026. The number of shares beneficially owned following the reported transaction was shown as 26,207 shares, but should have been 24,222. This number accounts for Aethlon's recent reverse stock split.
Open filing 0001683168-26-007880 Read from the filing’s XML Dispute this row
2026-04-17 Filed 2026-04-21Gikakis Nicolas Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)21,8152.29
49,956.35

Derived: shares × price per share. Exact value 49956.35.

22,844Direct (D) No
F1
  • F1 The Reporting Person was granted RSUs that vest in four equal quarterly installments on each of June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027, subject to the Reporting Person's continued service with the Company on each such vesting date.
Open filing 0001683168-26-003112 Read from the filing’s XML Dispute this row
2026-04-17 Filed 2026-04-21BROENNIMAN EDWARD G Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)21,8152.29
49,956.35

Derived: shares × price per share. Exact value 49956.35.

23,454Direct (D) No
F1
  • F1 The Reporting Person was granted RSUs that vest in four equal quarterly installments on each of June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027, subject to the Reporting Person's continued service with the Company on each such vesting date.
Open filing 0001683168-26-003111 Read from the filing’s XML Dispute this row
2026-04-17 Filed 2026-04-21Rossetti Angela Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)21,8152.29
49,956.35

Derived: shares × price per share. Exact value 49956.35.

26,207Direct (D) No
F1
  • F1 The Reporting Person was granted RSUs that vest in four equal quarterly installments on each of June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027, subject to the Reporting Person's continued service with the Company on each such vesting date.
Open filing 0001683168-26-003114 Read from the filing’s XML Dispute this row
2026-04-17 Filed 2026-04-21Shah Chetan Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)21,8152.29
49,956.35

Derived: shares × price per share. Exact value 49956.35.

23,021Direct (D) No
F1
  • F1 The Reporting Person was granted RSUs that vest in four equal quarterly installments on each of June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027, subject to the Reporting Person's continued service with the Company on each such vesting date.
Open filing 0001683168-26-003113 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-04-01Shah Chetan Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)1782.19
389.82

Derived: shares × price per share. Exact value 389.82.

1,463Direct (D) No
F1
  • F1 The Reporting Person forfeited 178 shares of common stock upon conversion of an aggregate 268 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025.
Open filing 0001683168-26-002589 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-04-01Gikakis Nicolas Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)1782.19
389.82

Derived: shares × price per share. Exact value 389.82.

1,464Direct (D) No
F1
  • F1 The Reporting Person forfeited 178 shares of common stock upon conversion of an aggregate 268 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025.
Open filing 0001683168-26-002588 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-04-01BROENNIMAN EDWARD G Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)892.19
194.91

Derived: shares × price per share. Exact value 194.91.

1,915Direct (D) No
F1
  • F1 The Reporting Person forfeited 89 shares of common stock upon conversion of an aggregate 357 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025.
Open filing 0001683168-26-002587 Read from the filing’s XML Dispute this row
2025-12-31 Filed 2026-01-02Shah Chetan Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)1792.77
495.83

Derived: shares × price per share. Exact value 495.83.

2,356Direct (D) No
F1
  • F1 The Reporting Person forfeited 179 shares of common stock upon conversion of an aggregate 268 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025.
Open filing 0001683168-26-000052 Read from the filing’s XML Dispute this row
2025-12-31 Filed 2026-01-02Gikakis Nicolas Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)1792.77
495.83

Derived: shares × price per share. Exact value 495.83.

2,357Direct (D) No
F1
  • F1 The Reporting Person forfeited 179 shares of common stock upon conversion of an aggregate 268 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025.
Open filing 0001683168-26-000051 Read from the filing’s XML Dispute this row
2025-12-31 Filed 2026-01-02BROENNIMAN EDWARD G Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)892.77
246.53

Derived: shares × price per share. Exact value 246.53.

2,807Direct (D) No
F1
  • F1 The Reporting Person forfeited 89 shares of common stock upon conversion of an aggregate 357 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025.
Open filing 0001683168-26-000049 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-18. Prior quarter ending 2026-06-30: 9,170 filings read.

Showing 1–17 of 17

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
STEMPOINT CAPITAL LP 213,685 SH1,393,226 dollarsNot in the prior quarter’s filings read Open filing 0001420506-26-002774 Filed 2026-11-16 Dispute this row
Birchview Capital, LP 62,837 SH409,697 dollarsNot in the prior quarter’s filings read Open filing 0001618205-26-000005 Filed 2026-11-13 Dispute this row
Shay Capital LLC 62,249 SH405,863 dollarsHigher by 31,177 Prior quarter: 31,072Open filing 0001723643-26-000008 Filed 2026-11-16 Dispute this row
DIADEMA PARTNERS LP 50,000 SH326,000 dollarsNot in the prior quarter’s filings read Open filing 0001892688-26-000170 Filed 2026-11-16 Dispute this row
Schonfeld Strategic Advisors LLC 25,769 SH168,012 dollarsNot in the prior quarter’s filings read Open filing 0001665241-26-000003 Filed 2026-11-16 Dispute this row
HRT FINANCIAL LP 21,643 SH141 dollarsLower by 51,100 Prior quarter: 72,743Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row
JANE STREET GROUP, LLC Partly reported under another manager21,534 SH140,402 dollarsLower by 17,346 Prior quarter: 38,880Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
StoneX Group Inc. Partly reported under another manager14,861 SH30,614 dollarsNot in the prior quarter’s filings read Open filing 0000913760-26-000042 Filed 2026-11-03 Dispute this row
FNY Investment Advisers, LLC 14,500 SH94 dollarsNot in the prior quarter’s filings read Open filing 0001742998-26-000005 Filed 2026-10-16 Dispute this row
Persistent Asset Partners Ltd 12,700 SH82,804 dollarsNot in the prior quarter’s filings read Open filing 0002056052-26-000005 Filed 2026-11-13 Dispute this row
LEVEL FOUR ADVISORY SERVICES, LLC 10,000 SH65,200 dollarsNot in the prior quarter’s filings read Open filing 0001696715-26-000006 Filed 2026-11-06 Dispute this row
Tower Research Capital LLC (TRC) Partly reported under another manager2,620 SH17,082 dollarsLower by 3,711 Prior quarter: 6,331Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row
UBS Group AG Partly reported under another manager2,605 SH16,985 dollarsLower by 6,271 Prior quarter: 8,876Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
MORGAN STANLEY Partly reported under another manager494 SH3,221 dollarsLower by 1,978 Prior quarter: 2,472Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
JONES FINANCIAL COMPANIES LLLP Partly reported under another manager3 SH19 dollarsLower by 14 Prior quarter: 17Open filing 0001193125-26-459442 Filed 2026-11-13 Dispute this row
BlackRock, Inc. Partly reported under another manager3 SH20 dollarsLower by 7 Prior quarter: 10Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
GROUP ONE TRADING LLC 2 SH13 dollarsLower by 12 Prior quarter: 14Open filing 0000932540-26-000017 Filed 2026-11-10 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • CITADEL ADVISORS LLC 42,977 SH
  • Virtu Financial LLC 27,815 SH
  • Ikarian Capital, LLC 14,364 SH
  • GEODE CAPITAL MANAGEMENT, LLC 10,189 SH
  • Scientech Research LLC 10,054 SH
  • MERCER GLOBAL ADVISORS INC /ADV 16 SH
  • Integrated Wealth Concepts LLC 15 SH
  • WELLS FARGO COMPANY/MN 3 SH
  • NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 2 SH
  • DANSKE BANK A/S 1 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
JANE STREET GROUP, LLC Common Stock, $0.001 par value per share5.035,819.0010/06/2026 Filed 2026-10-13SCHEDULE 13GOpen filing 0001595888-26-000121 Dispute this row
Jane Street Capital, LLC Common Stock, $0.001 par value per share1.06,845.0010/06/2026 Filed 2026-10-13SCHEDULE 13GOpen filing 0001595888-26-000121 Dispute this row
Jane Street Global Trading, LLC Common Stock, $0.001 par value per share4.128,974.0010/06/2026 Filed 2026-10-13SCHEDULE 13GOpen filing 0001595888-26-000121 Dispute this row
Mitchell P. Kopin Common Stock, par value $0.001 per share2.355,556.0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 2Open filing 0001213900-26-088823 Dispute this row
Daniel B. Asher Common Stock, par value $0.001 per share2.355,556.0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 2Open filing 0001213900-26-088823 Dispute this row
Intracoastal Capital LLC Common Stock, par value $0.001 per share2.355,556.0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 2Open filing 0001213900-26-088823 Dispute this row
Armistice Capital, LLC Common Stock, $0.001 par value per share4.9982,410.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0001172661-26-002117 Dispute this row
Steven Boyd Common Stock, $0.001 par value per share4.9982,410.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0001172661-26-002117 Dispute this row
Armistice Capital, LLC Common stock, par value $0.0001 per share9.9984,496.0012/31/2025 Filed 2026-02-17SCHEDULE 13GOpen filing 0001172661-26-001265 Dispute this row
Steven Boyd Common stock, par value $0.0001 per share9.9984,496.0012/31/2025 Filed 2026-02-17SCHEDULE 13GOpen filing 0001172661-26-001265 Dispute this row
Alumni Capital LP Common Stock4.0555,555.0010/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001213900-26-017603 Dispute this row
Alumni Capital GP LLC Common Stock4.0555,555.0010/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001213900-26-017603 Dispute this row
Ashkan Mapar Common Stock4.0555,555.0010/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001213900-26-017603 Dispute this row
Ikarian Capital, LLC Common Stock, $0.001 par value per share2.015,36609/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001193125-25-283459 Dispute this row
Neil Shahrestani Common Stock, $0.001 par value per share2.015,36609/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001193125-25-283459 Dispute this row
Armistice Capital, LLC COMMON STOCK, $0.001 PAR VALUE4.99136,486.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 2Open filing 0001172661-25-005169 Dispute this row
Steven Boyd COMMON STOCK, $0.001 PAR VALUE4.99136,486.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 2Open filing 0001172661-25-005169 Dispute this row
Alumni Capital LP Common Stock9.58781,110.0009/04/2025 Filed 2025-09-22SCHEDULE 13GOpen filing 0001213900-25-090293 Dispute this row
Alumni Capital GP LLC Common Stock9.58781,110.0009/04/2025 Filed 2025-09-22SCHEDULE 13GOpen filing 0001213900-25-090293 Dispute this row
Ashkan Mapar Common Stock9.58781,110.0009/04/2025 Filed 2025-09-22SCHEDULE 13GOpen filing 0001213900-25-090293 Dispute this row
Mitchell P. Kopin Common Stock, par value $0.001 per share7.7576,603.0009/04/2025 Filed 2025-09-10SCHEDULE 13GOpen filing 0001213900-25-086628 Dispute this row
Daniel B. Asher Common Stock, par value $0.001 per share7.7576,603.0009/04/2025 Filed 2025-09-10SCHEDULE 13GOpen filing 0001213900-25-086628 Dispute this row
Intracoastal Capital LLC Common Stock, par value $0.001 per share7.7576,603.0009/04/2025 Filed 2025-09-10SCHEDULE 13GOpen filing 0001213900-25-086628 Dispute this row
Armistice Capital, LLC COMMON STOCK, $0.001 PAR VALUE7.16185,000.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0001172661-25-003612 Dispute this row
Steven Boyd COMMON STOCK, $0.001 PAR VALUE7.16185,000.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0001172661-25-003612 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,540,664 filings read, dated 2004-06-14 to 2026-11-18: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020166,957
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026262,403

Filings made before the SEC required XML are listed, not extracted.

Back to Aethlon Medical, Inc.